Serum levels of soluble TL1A were detected in a fraction of CLL patients (14/26; 54%; σ2 = 9036) and healthy donors (6/11; 54%; σ2 = 4721). Here, TNFSF15 is linked to B-cell chronic lymphocytic leukemia.